PHARMACOTHERAPEUTIC FOLLOW-UP IN POSTPARTUM DEPRESSION

Abstract

Introduction: This article aimed to discuss postpartum depression (PPD), which is a condition characterized by physical, emotional, social, and hormonal changes. Women in the postpartum period are more susceptible to the emergence of these symptoms, with about 56% of Latina women being affected. This condition triggers negative and long-lasting effects on the health of both the mother and the baby. The literature points to several factors associated with PPD, such as low social support, lack of family planning, presence of anxiety, among others. Treatment includes antidepressants, hormone therapy, neuromodulation, and psychotherapy. Methods: The study's methodology highlights the need for more research to improve the diagnosis and treatment of PPD, as well as the importance of reducing stigma and increasing access to mental health care for mothers. Objective: To study pharmacotherapeutic monitoring in PPD. Specific objectives: List the main medications in PPD; understand the role of the pharmacist in pharmacological guidance in the treatment of PPD; highlight the importance of treating PPD to improve quality of life. Conclusions: The study supports the idea that pharmacists play an important role in improving maternal mental health, and this role could be better utilized. It is essential to have more training, policies that promote the integration of pharmacists into mental health services, and to provide effective support to these women during their treatment.